🏆Among Medical apps bottom 0% by installs gained this week (123 peers growing)
🛠Updatesdormant · updated 905 days ago
Installs since launch
0 installs
since Sep 29
Update history
5.0.700.01-prodMay 20, 2024 · seen Sep 29, 2026
Bug fixes and performance improvements.
Only the current version so far — new entries appear as the app ships updates.
CA116-003 is a medical app by Medable Inc. with 5+ downloads (about 9 estimated). Released Oct 18, 2022. Install growth, rank history, SDKs and ad networks.
From the store listing: “You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.”
